The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies
Luping Lin(University of California, San Francisco), Amit J. Sabnis(University of California, San Francisco), Elton Chan(University of California, San Francisco), Victor Olivas(University of California, San Francisco), Lindsay Cade(University of California, San Francisco), Evangelos Pazarentzos(University of California, San Francisco), Saurabh Asthana(University of California, San Francisco), Dana S. Neel(University of California, San Francisco), Jenny Yan(University of California, San Francisco), Xinyuan Lu(University of California, San Francisco), Luu Pham(University of California, San Francisco), Mingxue M Wang(University of California, San Francisco), Niki Karachaliou(Institut Català d'Oncologia), María González Cao(Institut Català d'Oncologia), José Luís Manzano(Institut Català d'Oncologia), José Luis Ramírez(Institut Català d'Oncologia), J.M. Sanchez Torres(Hospital Universitario de La Princesa), Fiamma Buttitta(University of Chieti-Pescara), Charles M. Rudin(Memorial Sloan Kettering Cancer Center), Eric A. Collisson(University of California, San Francisco), Alain P. Algazi(University of California, San Francisco), Eric M. Robinson(New York University), Iman Osman(New York University), Eva Muñoz‐Couselo(Vall d'Hebron Institute of Oncology), Javier Cortés(Vall d'Hebron Institute of Oncology), Dennie T. Frederick(Massachusetts General Hospital), Zachary A. Cooper(The University of Texas MD Anderson Cancer Center), Martin McMahon(University of California, San Francisco), Antonio Marchetti(University of Chieti-Pescara), Rafael Rosell(Institut Català d'Oncologia), Keith T. Flaherty(Massachusetts General Hospital), Jennifer A. Wargo(The University of Texas MD Anderson Cancer Center), Trever G. Bivona(University of California, San Francisco)
Cited by 553Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis